Oxford University Press's
Academic Insights for the Thinking World

  • Author: Charlie Schmidt

Reconsidering prostate cancer screening

In 2011, the US Preventive Services Task Force (USPSTF) issued its controversial draft recommendation against measuring prostate-specific antigen (PSA) in blood to screen for prostate cancer, claiming the test didn’t save lives. USPSTF is an independent panel of national experts convened by Congress to make evidence-based recommendations on preventive care.

Read More

Metastatic cells colonize implantable scaffold in mice

Cancer treatment’s biggest failings occur in the metastatic setting, when metastatic cells escaping from the primary tumor colonize and attack critical organs. Much about how cells colonize distant tissues as opposed to remaining in the primary tumor or in circulation without settling in one place remains unknown. But a new bioengineered device could offer insights.

Read More

Elective neck dissection in early oral cancer: debate resolved

A debate over whether to remove lymph nodes from the neck during surgical treatment of early oral cancer has gone on for decades. Now findings from a randomized control trial reported last June at the American Society of Clinical Oncology’s (ASCO) annual meeting, in Chicago may finally put that controversy to rest.

Read More